Coston, McIsaac & Partners »

Northwest Biotherapeutics In shares owned by Coston, McIsaac & Partners

Quarter-by-quarter ownership of Northwest Biotherapeutics In (NWBO) shares owned by Coston, McIsaac & Partners from 13F filings

Historical chart of Coston, McIsaac & Partners investment in Northwest Biotherapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Northwest Biotherapeutics In held by Coston, McIsaac & Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Northwest Biotherapeutics In by Coston, McIsaac & Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 1.0k 0.00
2024-06-30 $0 1.0k 0.00
2024-03-31 $0 1.0k 0.00
2023-12-31 $0 1.0k 0.00
2023-09-30 $0 1.0k 0.00

More positions owned by Coston, McIsaac & Partners

Dfa Global Equity I Equity Funds (DGEIX)
Vanguard Dividend Appreciation Etf Uit Exchange Traded (VIG)
Vanguard Total Stock Market Etf Uit Exchange Traded (VTI)
Berkshire Hathaway Class B Common Stock (BRK.B)
Apple Common Stock (AAPL)
Proshares S&p 500 Div Aristocrat Etf Uit Exchange Traded (NOBL)
Williams Sonoma Common Stock (WSM)
Walmart Common Stock (WMT)
Vanguard Ftse All World Ex Us Etf Uit Exchange Traded (VEU)
Procter & Gamble Common Stock (PG)
The Coca-cola Common Stock (KO)
Mcdonalds Corp Common Stock (MCD)
Ingredion Common Stock (INGR)
Southern Common Stock (SO)
Pepsico Common Stock (PEP)

View all positions for Coston, McIsaac & Partners

Top funds holding Northwest Biotherapeutics In

Moloney Securities Asset Management
Opus Capital Group
Williams Jones Wealth Management
Ethos Financial Group
MAI Wealth Advisors
Lee, Danner & Bass
AlphaMark Advisors
Advisors Management Group
Kitzinger Lautmann Capital Management
Coston, McIsaac & Partners
Hantz Financial Services

View all funds holding Northwest Biotherapeutics In